Correction: Discovery of a FLT3 inhibitor LDD1937 as an anti-leukemic agent for acute myeloid leukemia
Metrics: PDF 1798 views | ?
1 College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju, Republic of Korea
2 School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea
3 Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea
4 Gyeongnam Department of Environment Toxicology and Chemistry, Korea Institutes of Toxicology, Jinju, Republic of Korea
5 College of Pharmacy and BK21PLUS R-FIND Team, Dongguk University-Seoul, Goyang, Republic of Korea * These authors contributed equally to the work
Published: April 13, 2018
This article has been corrected: The correct author affiliations citations are given below:
Hyo Jeong Lee1,*, Jungeun Lee2,*, Pyeonghwa Jeong3,*, Jungil Choi4, Juhwa Baek1, Su Jin Ahn1, Yeongyu Moon4, Jeong Doo Heo4, Young Hee Choi5, Young-Won Chin5, Yong-Chul Kim2,3 and Sun-Young Han1
Original article: Oncotarget. 2018; 9:924-936. DOI: https://doi.org/10.18632/oncotarget.23221.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.